Form 4: AbbVie EVP, GC, and Secretary Perry C. Siatis Sells Shares Under 10b5-1 Plan

Perry C. Siatis, EVP, GC, and Secretary of AbbVie Inc., sold a total of 5,778 shares of common stock on February 20, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On February 20, 2025, Perry C. Siatis, an Executive Vice President, General Counsel, and Secretary at AbbVie Inc., sold 1,784 shares of AbbVie's common stock at a weighted average price of $197.4.
• Additionally, Siatis sold 3,994 shares at a weighted average price of $198.12.
• These transactions were executed under a Rule 10b5-1 trading plan established on November 19, 2024.
• Following these sales, Siatis directly owns 22,381 shares of AbbVie common stock.

Sentiment

Score: 5

Explanation: The document simply reports the sale of shares by an executive under a pre-existing plan. It is a neutral event.

Industry Context

Sales by company insiders are a normal part of corporate activity; however, they are closely scrutinized by investors. A pre-arranged 10b5-1 trading plan allows corporate insiders to sell company stock over a period of time, mitigating concerns about trading on inside information.

Stakeholder Impact

• The sale of shares by an executive could have a minor negative impact on shareholder sentiment, but the existence of a 10b5-1 plan mitigates this concern.

Key Dates

Keywords

AbbVie, ABBV, Perry C. Siatis, Executive Vice President, General Counsel, Secretary, Form 4, SEC, Share Sale, Rule 10b5-1 plan, Insider Trading